Pictet Asset Management
XENE icon

Pictet Asset Management’s Xenon Pharmaceuticals XENE Stock Holding History

Pictet Asset Management’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$71.6M Buy
1,187,723
+508,014
+75% +$28.2M 0.07% 269
2026
Q1 		$39.2M Buy
679,709
+53,724
+9% +$2.48M 0.04% 360
2025
Q4 		$28M Sell
625,985
-636,594
-50% -$26.7M 0.03% 445
2025
Q3 		$50.6M Sell
1,262,579
-211,870
-14% -$7.46M 0.05% 324
2025
Q2 		$46.2M Sell
1,474,449
-3,168
-0.2% -$103K 0.05% 327
2025
Q1 		$49.6M Sell
1,477,617
-18,894
-1% -$717K 0.06% 300
2024
Q4 		$58.7M Sell
1,496,511
-32,303
-2% -$1.34M 0.06% 270
2024
Q3 		$60.2M Buy
1,528,814
+49,323
+3% +$1.99M 0.07% 263
2024
Q2 		$57.7M Sell
1,479,491
-35,935
-2% -$1.44M 0.07% 257
2024
Q1 		$65.2M Sell
1,515,426
-524,974
-26% -$24.1M 0.07% 266
2023
Q4 		$94M Buy
2,040,400
+101,621
+5% +$3.59M 0.1% 212
2023
Q3 		$66.2M Buy
+1,938,779
New +$72.5M 0.08% 243

Other funds holding XENE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Pictet Asset Management's XENE Position: Q2 2026 in Review

Pictet Asset Management increased its Xenon Pharmaceuticals (XENE) stake by 75% in Q2 2026, buying an estimated $28.2M and bringing the position to 1,187,723 shares worth $71.6M. The position accounts for 0.07% of the portfolio, ranked #269.

Pictet Asset Management first reported a position in XENE in Q3 2023 and has held it in 12 quarters since. The position peaked at $94M in Q4 2023. 96 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • Pictet Asset Management held 1,187,723 shares of Xenon Pharmaceuticals worth $71.6M as of Q2 2026.
  • Pictet Asset Management bought 508,014 Xenon Pharmaceuticals shares in Q2 2026, an estimated $28.2M.
  • Xenon Pharmaceuticals made up 0.07% of Pictet Asset Management's portfolio in Q2 2026, its #269 holding.
  • Pictet Asset Management first reported a position in Xenon Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • Pictet Asset Management's Xenon Pharmaceuticals position peaked at $94M in Q4 2023.
  • 96 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.